Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IonMAN Trial-First in Human Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System

NCT05364697 is registered in ClinicalTrials.gov with Medinol Ltd. as lead sponsor.

NCT NCT05364697
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05364697 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IonMAN Trial-First in Human Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System
Lead sponsor
Medinol Ltd.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 30, 2022
Completion date
December 31, 2029
Enrollment
60 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, coronary disease, coronary stenosis, non-st elevated myocardial infarction